Imiquimod: mode of action and therapeutic potential.
Chosidow
Olivier
O
Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, 47-83 Bd de l'Hôpital, Paris, France. olivier.chosidow@psl.ap-hop-paris.fr
Dummer
Reinhard
R
D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use; D000634:Aminoquinolines / Q000494:pharmacology* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D006801:Humans; D000077271:Imiquimod; D007107:Immune System / Q000187:drug effects* / Q000276:immunology; D027383:Papillomaviridae / Q000187:drug effects; D030361:Papillomavirus Infections / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology; D012878:Skin Neoplasms / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod